Literature DB >> 24487475

Myoepithelioma of the ovary: first reported case.

Oisín P Houghton1, Vaiyapuri P Sumathi, Sabine A J Loyson, W Glenn McCluggage.   

Abstract

A wide variety of neoplasms of varying histogenesis occur within the ovary. We report the first case of a primary ovarian myoepithelioma, a diagnosis made on the basis of the morphologic features coupled with immunoreactivity with epithelial and myoid markers. The tumor had a lobulated appearance with variable architectural patterns including anastomosing cords, trabeculae, and nests of epithelioid to spindled tumor cells within a hyalinised and focally myxoid stroma. Fluorescence in situ hybridization for EWS gene rearrangement and reverse transcriptase polymerase chain reaction for EWSR1-POU5F1 and EWSR1-PBX1, molecular abnormalities which are found in some extrasalivary myoepitheliomas, were negative. In reporting this unique neoplasm, we discuss the wide differential diagnosis generated by the case.

Entities:  

Mesh:

Year:  2014        PMID: 24487475     DOI: 10.1097/PGP.0b013e3182995209

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  2 in total

1.  A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases.

Authors:  Jennifer A Bennett; Robert H Young; Brooke E Howitt; Sabrina Croce; Pankhuri Wanjari; Chaojie Zhen; Arnaud Da Cruz Paula; Emily Meserve; J Kenneth Schoolmeester; Sofia Westbom-Fremer; Eduardo Benzi; Ninad M Patil; Loes Kooreman; Mona El-Bahrawy; Gian Franco Zannoni; Thomas Krausz; W Glenn McCluggage; Britta Weigelt; Lauren L Ritterhouse; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2021-08-01       Impact factor: 6.298

2.  Myoepithelioma of the lateral abdominal wall: A case report.

Authors:  Linghong Guo; Fuqing Zhou; Ning Zhang; Hua Dai; Xianjun Zeng; Honghan Gong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.